Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001

Summary

This is an open, multi-center, Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics/pharmacokinetics and initial efficacy of FTL001 in patients with advanced and metastatic solid tumors.

Timeline

Start

2023-06-05

Primary completion

2026-01

Completion

2027-03

Drugs

Indications